Evidence map›Paper›PMID 29437596›Full record

Observational studyJournal of the American Heart Association2018

Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study.

Alexander C Fanaroff, Lisa A Kaltenbach, Eric D Peterson, Mohammed W Akhter, Mark B Effron, Timothy D Henry, Tracy Y Wang

Registry-linked trialOpen access · goldAbstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01088503 (The TRANSLATE-ACS Study), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01088503 completednot on this map

The TRANSLATE-ACS Study: Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome

TypeobservationalSponsorEli Lilly and CompanyRan2010 to 2014Enrolled12,227ConditionsAcute Coronary SyndromeArmsADP receptor inhibitors
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Drug-eluting stent thrombosis: current and future perspectives.Cardiovascular intervention and therapeutics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Alexander C FanaroffDivision of Cardiology, Duke University, Durham, NC alexander.fanaroff@duke.edu.
Lisa A KaltenbachDuke Clinical Research Institute, Duke University, Durham, NC.
Eric D PetersonDivision of Cardiology, Duke University, Durham, NC.
Mohammed W AkhterDivision of Cardiology, University of Massachusetts Medical Center, Worcester, MA.
Mark B EffronDivision of Cardiology, John Ochsner Heart and Vascular Institute, New Orleans, LA.
Timothy D HenryDivision of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA.
Tracy Y WangDivision of Cardiology, Duke University, Durham, NC.
Clinical Research Institute · USDuke University · USOchsner Medical Center · USUniversity of Massachusetts Chan Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGuidelines recommend P2Y METHODS AND

resultsThe TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) study enrolled 12 365 patients with MI treated with percutaneous coronary intervention. We examined whether P2Y

conclusionsFew patients after MI with a recurrent ischemic event who were taking clopidogrel switched to a more potent P2Y CLINICAL

trial registrationURL: https://www.clinicaltrials.gov. Unique identifier: NCT01088503.

Indexed as

Percutaneous Coronary InterventionAcute Coronary SyndromeAgedClopidogrelCoronary ThrombosisDrug Administration ScheduleDrug-Eluting StentsDrug SubstitutionFemaleHumansLongitudinal StudiesMaleMiddle AgedPlatelet Aggregation InhibitorsPractice Patterns, Physicians'Prasugrel HydrochlorideClopidogrelPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsTicagrelorclopidogrelcoronary revascularizationmyocardial infarctionsecondary preventionstent thrombosis

Identifiers

PMID29437596
PMCPMC5850204
OpenAlexW2790034794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.